Ask HopeStage to review this study with me
Study ID: NCT07418554. We help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07418554
Pediatric, prolonged released melatonin for PTSD
This study is not yet recruiting in France. It is testing pediatric, prolonged released melatonin for PTSD.
PTSD, PTSD (PTSD), ...DrugFrom 2 Years to 18 Years
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
France · 1 site
- Hôpitaux Universitaires de StrasbourgStrasbourgSite status: Not listed — confirm with the team
Key information made simple
What is this study testing?
This study is testing whether pediatric, prolonged released melatonin may be useful for adolescents experiencing ptsd.
What would participation involve?
Participants may receive pediatric, prolonged released melatonin, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in France.
Who is it mainly for?
This study appears to be mainly for adolescents with ptsd. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateEstimated: January 1, 2027
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 2 Years to 18 Years
- Official registry ID
- NCT07418554
- Official title
- Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT07418554. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: Among the most sensitive and persistent symptoms of post-traumatic stress disorder (PTSD) in children are sleep disturbances in the insomnia spectrum (sleep onset disturbances, fragmented sleep with multiple nocturnal awakening, early morning awakening) as well as nightmares,. The study team can confirm the exact objective and what it means for you.
Does this study involve a medication?
This appears to be a medication / drug study involving pediatric, prolonged released melatonin, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with ptsd; age range: From 2 Years to 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by University Hospital, Strasbourg, France, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not Yet RecruitingNCT07207018
Early Intervention After Traumatic Exposure in Children and Adolescents
This study is not yet recruiting. It focuses on PTSD and currently lists study information in France.
Not Yet RecruitingNCT07307937
Movement Sonification as an add-on to Immediate Post-event Psychotherapeutic Intervention in the Management of Acute Stress Disorder: a Feasibility and Acceptability Study
This study is not yet recruiting in France. It focuses on PTSD.
Not Yet RecruitingNCT07456384
Sensory Stimulation Program Delivered by Family Members of Brain-injured Patients in Critical Care: Effect on Relatives' Post-traumatic Stress
This study is not yet recruiting. It focuses on PTSD and currently lists study information in France.